Poland· PL-100059409
Sal Vichy factitium
A antacids, other combinations product containing produkt złożony, registered in Poland by Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Produkt złożony is registered in 6 of 19 countries.
Countries holding a registration under ATC A02AX (antacids, other combinations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Produkt złożony · ATC A02AX
6 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- Przedsiębiorstwo Farmaceutyczne Ziołolek Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A02AX
- ATC class
- Antacids, other combinations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990193417
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A02AX
Antacids, other combinations, as other registers publish it.
- SwitzerlandGaviscon Dual Liquid, Suspension zum Einnehmen in SachetsReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Dual, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
- SwitzerlandGaviscon Erdbeer, KautablettenReckitt Benckiser (Switzerland) AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b68f2f9d-0dcd-4b7d-bf43-829624c786b5 GET /v1/drugs/b68f2f9d-0dcd-4b7d-bf43-829624c786b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki musujące",
"source": "urpl",
"strength": "-",
"packaging": "OTC ¦ Skasowane ¦ 8867\n80 tabl.\n05909990193417 ¦ OTC ¦ 62671\n40 tabl.",
"substance": "Natrii chloridum 45 mg + Natrii hydrogenocarbonas 498 mg + Kalii hydrogenocarbonas 21 mg + Natrii sulfas anhydricus 24 mg + Natrii hydrophosphas 12 mg",
"common_name": "Produkt złożony",
"pl_product_id": "100059409",
"pozwolenie_nr": "01934",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about produkt złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.